세계의 세포 건강 스크리닝 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 검사 유형별, 검체 채취 부위별, 지역별, 경쟁 시장별(2020-2030년)
Cellular Health Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Test Type, By Sample, By Site of Collection, By Region and Competition, 2020-2030F
상품코드:1738371
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 세포 건강 스크리닝 시장은 2024년에 33억 2,000만 달러로 평가되었고, 2030년에는 56억 7,000만 달러에 이를 전망이며, CAGR 9.33%로 확대될 것으로 예측됩니다.
이 시장은 라이프 스타일과 관련된 건강 리스크, 세계 인구의 고령화, 당뇨병, 비만, 암 등의 질병 증가로 현저한 성장을 이루고 있습니다. 균형 잡힌 식사나 정기적인 운동을 통해 건강한 생활을 촉진하는 것을 목적으로 한 텔로미어 퍼포먼스 프로그램의 이용이 증가하고 있는 것이 시장의 수요를 더욱 끌어올리고 있습니다. 게다가 소비자 직접 검사 서비스의 인기의 고조나, 수명이나 예방 헬스케어에 대한 의식의 고조도, 시장 확대에 기여하고 있습니다. 만성질환 및 노화와 관련된 질환이 특히 노인들 사이에서 만연함에 따라 세포 선별의 수요는 확대될 전망입니다. 또, 식생활의 혼란이 암 이환율 상승으로 이어져, 조기 발견과 개별화된 건강 평가의 필요성이 더욱 높아지고 있는 것도 시장을 뒷받침하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
33억 2,000만 달러
시장 규모(2030년)
56억 7,000만 달러
CAGR(2025-2030년)
9.33%
급성장 부문
멀티테스트 패널
최대 시장
북미
시장 성장 촉진요인
만성 질환 유병률 상승
주요 시장 과제
높은 비용 및 제한된 접근성
주요 시장 동향
스크리닝 방법에서 첨단 기술 통합
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 세포 건강 스크리닝 시장 전망
시장 규모 및 예측
금액별
시장 점유율 및 예측
테스트 유형별(단일 테스트 패널, 복수 테스트 패널)
시료(혈액, 타액, 소변, 기타)
채취 장소별(자택, 병원 및 진료소, 진단 실험실, 기타)
지역별
기업별(2024년)
시장 맵
테스트 유형별
샘플별
수집 장소별
지역별
제6장 북미의 세포 건강 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 세포 건강 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 세포 건강 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 세포 건강 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 세포 건강 스크리닝 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향 및 발전
최근 동향
합병 및 인수
제품 출시
제13장 세계의 세포 건강 스크리닝 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협/서비스
제15장 경쟁 구도
Telomere Diagnostics, Inc.
Quest Diagnostics, Inc.
Laboratory Corporation of America Holdings
SpectraCell Laboratories, Inc.
Cell Science Systems Corporation
Immundiagnostik AG
Repeat Diagnostics, Inc.
OPKO Health, Inc.
Genova Diagnostics, Inc.
Titanovo, Inc.
제16장 전략적 제안
제17장 기업 소개 및 면책사항
AJY
영문 목차
영문목차
The Global Cellular Health Screening Market was valued at USD 3.32 billion in 2024 and is projected to reach USD 5.67 billion by 2030, expanding at a CAGR of 9.33%. The market is witnessing significant growth due to lifestyle-related health risks, an aging global population, and a rise in conditions such as diabetes, obesity, and cancer. The increasing use of telomere performance programs, aimed at promoting healthy living through balanced diets and regular physical activity, is further driving market demand. Additionally, the growing popularity of direct-to-consumer testing services and heightened awareness around life expectancy and preventive healthcare contribute to market expansion. As chronic diseases and age-related conditions become more prevalent, especially among the elderly, the demand for cellular health screening is poised to grow. The market is also being fueled by poor dietary habits leading to rising cancer incidence, further reinforcing the need for early detection and personalized health assessments.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 3.32 Billion
Market Size 2030
USD 5.67 Billion
CAGR 2025-2030
9.33%
Fastest Growing Segment
Multi Test Panels
Largest Market
North America
Key Market Drivers
Rising Prevalence of Chronic Diseases
The global surge in chronic conditions-including diabetes, cancer, and cardiovascular diseases-is a major factor accelerating growth in the cellular health screening market. These diseases often develop without early symptoms, making timely detection essential. Cellular health screening helps identify changes at the cellular level before symptoms appear, enabling earlier interventions and more personalized treatment strategies. According to the WHO, chronic illnesses are responsible for 71% of all global deaths. In the U.S., CDC data shows that 6 in 10 adults suffer from at least one chronic disease, and 4 in 10 deal with two or more. This highlights the critical need for reliable and accessible early screening tools. In response, governments are investing in preventive healthcare innovations, such as the UK's funding of a £120 blood test for early cancer detection. As cellular health screening becomes more integrated into routine healthcare, it is expected to support better patient outcomes, reduce healthcare expenditures, and propel market growth.
Key Market Challenges
High Costs and Limited Accessibility
The high cost of cellular health screening technologies remains a major challenge to broader adoption. Procedures like telomere analysis and oxidative stress testing often require sophisticated laboratory infrastructure and trained personnel, increasing expenses for providers and patients alike. This cost burden is particularly significant in developing countries where access to healthcare services is already limited. WHO estimates indicate that over 1 billion people worldwide are unable to obtain basic health services due to financial constraints. Additionally, in many regions, these screening procedures are not covered by insurance, further limiting accessibility. The lack of affordable, scalable options and reimbursement frameworks makes it difficult for a broader population to benefit from early disease detection, underscoring the need for cost-effective innovations and inclusive health policies.
Key Market Trends
Integration of Advanced Technologies in Screening Methods
Technological advancements such as artificial intelligence (AI), machine learning, and high-throughput sequencing are playing a transformative role in cellular health screening. These innovations are improving the precision, speed, and efficiency of screening procedures, allowing for the detailed analysis of cellular and genetic data. AI-driven systems can identify early disease indicators by processing large volumes of data, while high-throughput sequencing offers deep insights into genomic profiles. Such technologies support personalized healthcare approaches, enabling treatments tailored to individual biological conditions. Government funding and industry partnerships are further supporting this technological shift. As these tools become more refined and widespread, they are expected to significantly enhance diagnostic capabilities and expand the market's reach, ultimately improving healthcare outcomes on a global scale.
Key Market Players
Telomere Diagnostics, Inc.
Quest Diagnostics, Inc.
Laboratory Corporation of America Holdings
SpectraCell Laboratories, Inc.
Cell Science Systems Corporation
Immundiagnostik AG
Repeat Diagnostics, Inc.
OPKO Health, Inc.
Genova Diagnostics, Inc.
Titanovo, Inc.
Report Scope:
In this report, the Global Cellular Health Screening Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Cellular Health Screening Market, By Test Type:
Single Test Panels
Multi Test Panels
Cellular Health Screening Market, By Sample:
Blood
Saliva
Urine
Others
Cellular Health Screening Market, By Site of Collection:
Home
Hospitals & Clinics
Diagnostic Laboratories
Others
Cellular Health Screening Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Cellular Health Screening Market.
Available Customizations:
Global Cellular Health Screening Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cellular Health Screening Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test Type (Single Test Panels, Multi Test Panels)
5.2.2. By Sample (Blood, Saliva, Urine, Others)
5.2.3. By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
5.3.1. By Test Type
5.3.2. By Sample
5.3.3. By Site of Collection
5.3.4. By Region
6. North America Cellular Health Screening Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By Sample
6.2.3. By Site of Collection
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Cellular Health Screening Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Test Type
6.3.1.2.2. By Sample
6.3.1.2.3. By Site of Collection
6.3.2. Canada Cellular Health Screening Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Test Type
6.3.2.2.2. By Sample
6.3.2.2.3. By Site of Collection
6.3.3. Mexico Cellular Health Screening Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Test Type
6.3.3.2.2. By Sample
6.3.3.2.3. By Site of Collection
7. Europe Cellular Health Screening Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By Sample
7.2.3. By Site of Collection
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Cellular Health Screening Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Test Type
7.3.1.2.2. By Sample
7.3.1.2.3. By Site of Collection
7.3.2. Germany Cellular Health Screening Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Test Type
7.3.2.2.2. By Sample
7.3.2.2.3. By Site of Collection
7.3.3. United Kingdom Cellular Health Screening Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Test Type
7.3.3.2.2. By Sample
7.3.3.2.3. By Site of Collection
7.3.4. Italy Cellular Health Screening Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Test Type
7.3.4.2.2. By Sample
7.3.4.2.3. By Site of Collection
7.3.5. Spain Cellular Health Screening Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Test Type
7.3.5.2.2. By Sample
7.3.5.2.3. By Site of Collection
8. Asia-Pacific Cellular Health Screening Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By Sample
8.2.3. By Site of Collection
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Cellular Health Screening Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Test Type
8.3.1.2.2. By Sample
8.3.1.2.3. By Site of Collection
8.3.2. India Cellular Health Screening Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Test Type
8.3.2.2.2. By Sample
8.3.2.2.3. By Site of Collection
8.3.3. Japan Cellular Health Screening Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Test Type
8.3.3.2.2. By Sample
8.3.3.2.3. By Site of Collection
8.3.4. South Korea Cellular Health Screening Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Test Type
8.3.4.2.2. By Sample
8.3.4.2.3. By Site of Collection
8.3.5. Australia Cellular Health Screening Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Test Type
8.3.5.2.2. By Sample
8.3.5.2.3. By Site of Collection
9. South America Cellular Health Screening Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test Type
9.2.2. By Sample
9.2.3. By Site of Collection
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Cellular Health Screening Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Test Type
9.3.1.2.2. By Sample
9.3.1.2.3. By Site of Collection
9.3.2. Argentina Cellular Health Screening Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Test Type
9.3.2.2.2. By Sample
9.3.2.2.3. By Site of Collection
9.3.3. Colombia Cellular Health Screening Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Test Type
9.3.3.2.2. By Sample
9.3.3.2.3. By Site of Collection
10. Middle East and Africa Cellular Health Screening Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Test Type
10.2.2. By Sample
10.2.3. By Site of Collection
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Cellular Health Screening Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Test Type
10.3.1.2.2. By Sample
10.3.1.2.3. By Site of Collection
10.3.2. Saudi Arabia Cellular Health Screening Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Test Type
10.3.2.2.2. By Sample
10.3.2.2.3. By Site of Collection
10.3.3. UAE Cellular Health Screening Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Test Type
10.3.3.2.2. By Sample
10.3.3.2.3. By Site of Collection
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Cellular Health Screening Market: SWOT Analysis
